welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Earlier start of corticosteroids in DMD linked to earlier heart disease onset, study suggests
Researchers say it is important to carefully assess the timing of the start of corticosteroid treatment for Duchenne muscular dystrophy (DMD) in children and its potential association with disease outcomes.
The study, “Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy,” was published in the journal Neuromuscular Disorders.
DMD is an inherited childhood-onset disease characterized by mutations in the DMD gene that provides instructions for making a protein called dystrophin, located primarily in skeletal muscles used for movement and in the heart muscle. These mutations lead to progressive muscle weakness.
rareRelated
-
Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenn...Background:Corticosteroid treatment is c...
-
The impact of deflazacort on puberty in Duchenne muscular dystrophyBackground: The routine use of glucocor...
-
Developing standardized corticosteroid treatment for Duchenne muscular dystrophyDespite corticosteroids being the only t...
-
Electrical Impedance Myography and Quantitative Ultrasound Detect Steroid Related Improvements in Duchenne Muscular ...Objective:To determine whether electrica...
-
Corticosteroids for Duchenne Muscular DystrophyNeurologists from the American Academy o...
-
Effect of Deflazacort and Prednisone versus Placebo on Muscle Strength in Boys with Duchenne Muscular Dystrophy Who ...Objective: To assess the effects of def...
-
Finding the Optimum Regimen for Duchenne Muscular DystrophyThe Finding the Optimum Regimen for Duch...
